Finepoint Capital LP Portfolio Holdings

Finepoint Capital LP

  • $947 Million
  • Q1 2025

Finepoint Capital LP has filed its 13F form on May 14, 2025 for Q1 2025 where it was disclosed a total value porftolio of $947 Million distributed in 25 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Liberty Broadband Corp with a value of $45M, Spring Works Therapeutics, Inc. with a value of $32.2M, Ascendis Pharma A/S with a value of $28M, Revolution Medicines, Inc. with a value of $24.4M, and Moon Lake Immunotherapeutics with a value of $17M.

Examining the 13F form we can see an decrease of $234M in the current position value, from $1.18B to 947M.

Finepoint Capital LP is based out at Boston, MA

Below you can find more details about Finepoint Capital LP portfolio as well as his latest detailed transactions.

Portfolio value $947 Million
ETFs: $719 Million
Healthcare: $183 Million
Communication Services: $45 Million
Financial Services: $117,000

Stock Holdings Table Market Cap. of $50 Millions to $300 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$295M
$7.92 Million 0.84% of portfolio
640,071
Q1 2025 Reduced 2.59%

Summary

  • Portfolio
  • No. of Stocks 25
  • Current Value $947 Million
  • Prior Value $1.18 Billion
  • Filing
  • Period Q1 2025
  • Filing Date May 14, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 0 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 17 stocks
Track This Portfolio

Track Finepoint Capital LP Portfolio

Follow Finepoint Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Finepoint Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Finepoint Capital LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email